CIK: 1823057 - Address: C/O Quotient Limited, Business Park, Terre Bonne, Route De Crassier 13, Eysins, V8 1262
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/2/23 20:30
1/31/23
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.0000372D
11/2/22 20:00
10/31/22
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.00071747D
8/2/22 17:36
7/31/22
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.00072140D
5/3/22 19:44
4/30/22
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.00072633D
2/2/22 16:06
1/31/22
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.00073526D
11/2/21 19:01
10/31/21
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.00042520D
8/2/21 16:05
7/31/21
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.00043216D
5/3/21 16:05
4/30/21
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.00044812D
2/2/21 16:05
1/31/21
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.0004928D
11/3/20 17:40
10/31/20
QTNTQuotient LtdY9HealthDiagnIn Vitro & In Vivo DiagnosticLarue CatherineV8DM.d00.0004New4D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact